Equillium director Yu Xu resigns; Peter Colabuono appointed to board

Equillium, Inc.

Yu (Katherine) Xu, Ph.D., resigned from Equillium board and audit committee effective Dec 10, 2024; no disagreement cited.
Peter Colabuono appointed Class II director, term expiring at 2026 annual meeting, filling Xu's vacancy.
Colabuono receives $42,000 annual cash retainer, option for 40,000 shares vesting monthly over 3 years.
Further annual automatic option grants of 20,000 shares vesting over 12 months; change-in-control acceleration.
Barbara Troupin, M.D., appointed to audit committee; committee now Demski (chair), Manian, Troupin.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.